Abstract:The recent technical and computational advances in single-cell sequencing technologies have significantly broaden our toolkit to study tumor microenvironment (TME) directly from human specimens. The TME is the complex and dynamic ecosystem composed of multiple cell types, including tumor cells, immune cells, stromal cells, endothelial cells, and other non-cellular components such as the extracellular matrix and secreted signaling molecules. The great success on immune checkpoint blockade therapy has highlighted the importance of TME on anti-tumor immunity and has made it a prime target for further immunotherapy strategies. Applications of single-cell transcriptomics on studying TME has yielded unprecedented resolution of the cellular and molecular complexity of the TME, accelerating our understanding of the heterogeneity, plasticity, and complex cross-interaction between different cell types within the TME. In this review, we discuss the recent advances by single-cell sequencing on understanding the diversity of TME and its functional impact on tumor progression and immunotherapy response driven by single-cell sequencing. We primarily focus on the major immune cell types infiltrated in the human TME, including T cells, dendritic cells, and macrophages. We further discuss the limitations of the existing methodologies and the prospects on future studies utilizing single-cell multi-omics technologies. Since immune cells undergo continuous activation and differentiation within the TME in response to various environmental cues, we highlight the importance of integrating multimodal datasets to enable retrospective lineage tracing and epigenetic profiling of the tumor infiltrating immune cells. These novel technologies enable better characterization of the developmental lineages and differentiation states that are critical for the understanding of the underlying mechanisms driving the functional diversity of immune cells within the TME. We envision that with the continued accumulation of single-cell omics datasets, single-cell sequencing will become an indispensable aspect of the immune-oncology experimental toolkit. It will continue to drive the scientific innovations in precision immunotherapy and will be ultimately adopted by routine clinical practice in the foreseeable future.

Applications of Single-Cell Omics to Dissect Tumor Microenvironment

Applications of Single-Cell Omics in Tumor Immunology

Application of single-cell sequencing to the research of tumor microenvironment

Single-Cell Informatics for Tumor Microenvironment and Immunotherapy

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

High-throughput single-cell sequencing in cancer research

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer

Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics

Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Unravelling the Heterogeneity and Dynamic Relationships of Tumor-Infiltrating T Cells by Single-Cell RNA Sequencing Analysis

Understanding Tumor Ecosystems by Single-Cell Sequencing: Promises and Limitations

Extensive exploration of T cell heterogeneity in cancers by single cell sequencing.

[Advancements in Single-cell RNA Sequencing Technology in the Study of the Tumor Microenvironment in Lung Cancer]

Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis

Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level

Applications of single-cell analysis in immunotherapy for lung cancer: Current progress, new challenges and expectations

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution

Unravelling immune microenvironment features underlying tumor progression in the single-cell era

Heterogeneity of myeloid cells in common cancers: Single cell insights and targeting strategies